|
G |
MT3 |
metallothionein 3 |
multiple interactions |
EXP |
MT3 protein binds to and affects the metabolism of Hydroxyl Radical |
CTD |
PMID:12680700 |
|
NCBI chr 6:18,634,735...18,636,134
Ensembl chr 6:18,634,261...18,636,131
|
|
|
G |
ACE |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
multiple interactions |
EXP |
ACE protein inhibits the reaction [KNG1 protein results in increased abundance of Nitric Oxide] |
CTD |
PMID:12672649 |
|
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
|
|
G |
AGT |
angiotensinogen |
affects activity |
EXP |
Nitric Oxide affects the activity of AGT protein |
CTD |
PMID:21127344 |
|
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
|
|
G |
CAPN1 |
calpain 1 |
decreases expression |
EXP |
Nitric Oxide results in decreased expression of CAPN1 mRNA |
CTD |
PMID:9728040 |
|
NCBI chr 2:6,997,513...7,024,410
Ensembl chr 2:6,997,985...7,022,684
|
|
G |
EDN1 |
endothelin 1 |
increases abundance multiple interactions |
EXP |
EDN1 protein results in increased abundance of Nitric Oxide Nitric Oxide deficiency inhibits the reaction [Clofibrate results in decreased expression of EDN1 protein] |
CTD |
PMID:12672649 PMID:17105827 |
|
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
G |
KDSR |
3-ketodihydrosphingosine reductase |
multiple interactions |
EXP |
Nitric Oxide results in increased phosphorylation of and results in decreased activity of BCL2 protein |
CTD |
PMID:16039061 |
|
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
|
|
G |
KNG1 |
kininogen 1 |
multiple interactions increases abundance |
EXP |
ACE protein inhibits the reaction [KNG1 protein results in increased abundance of Nitric Oxide] |
CTD |
PMID:12672649 |
|
NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Resveratrol inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] |
CTD |
PMID:20825639 |
|
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions decreases activity |
EXP |
TXNRD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein] |
CTD |
PMID:8810647 PMID:10823391 |
|
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
|
|
G |
TAC1 |
tachykinin precursor 1 |
increases abundance |
EXP |
TAC1 protein results in increased abundance of Nitric Oxide |
CTD |
PMID:12672649 |
|
NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,536...77,206,523
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
multiple interactions |
EXP |
TXNRD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein] |
CTD |
PMID:8810647 |
|
NCBI chr 5:80,170,334...80,213,889
Ensembl chr 5:80,172,260...80,236,219
|
|
|
G |
MT3 |
metallothionein 3 |
multiple interactions |
EXP |
MT3 protein binds to and affects the metabolism of Superoxides |
CTD |
PMID:12680700 |
|
NCBI chr 6:18,634,735...18,636,134
Ensembl chr 6:18,634,261...18,636,131
|
|
G |
PRKG1 |
protein kinase cGMP-dependent 1 |
multiple interactions |
EXP |
Superoxides affects the reaction [Nitroglycerin results in increased activity of PRKG1 protein] |
CTD |
PMID:18037907 |
|
NCBI chr14:97,558,531...98,793,080
Ensembl chr14:97,558,533...98,793,010
|
|
G |
XDH |
xanthine dehydrogenase |
multiple interactions |
EXP |
[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Superoxides |
CTD |
PMID:21984542 |
|
NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
|
|